NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.
(NewsNation) — Multiple types of diabetes exist, but Type 1 and Type 2 are the most common. Of the estimated 38 million Americans diagnosed with diabetes, an overwhelming majority has Type 2. Diabetes ...
Eli Lilly and Company has reported detailed findings from the ACHIEVE-3 Phase III trial comparing the efficacy and safety of ...
Sleeping for 7 hours and 18 minutes every night may be the sweet spot for warding off the risk of insulin resistance—the ...
A recent study has found that eating higher levels of red meat is associated with an increased risk of developing type 2 ...
Read more about why patients with type 2 diabetes will now be offered SGLT-2 inhibitors much earlier in the treatment process.
The global type 2 diabetes market size surpassed USD 40.09 billion in 2025 and is projected to reach approximately USD 79.25 ...
More than 38 million Americans have diabetes and of them, up to 95% have type 2 diabetes, according to the Centers for Disease Control and Prevention (CDC). While the condition usually develops in ...
Type 2 diabetes is associated with twice the death rate of type 1 diabetes among people diagnosed in adolescence or early adulthood, and this is primarily driven by cardiovascular mortality, a new ...
Some research suggests that vitamin C supplements may benefit people with type 2 diabetes, but more studies are needed to understand the effects and recommended dosage. Vitamin C (L-ascorbic acid) is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results